Ethanol withdrawal and hyperalgesia

Current Drug Abuse Reviews

Volumn 2, Issue 1, 2009, Pages 41-50

  Gatch, Michael B ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Adenosine receptors; Calcium channels; Chronic ethanol exposure; GABA receptor; Hyperalgesia; NMDA receptor; Tolerance; Withdrawal

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; ADENOSINE RECEPTOR; ALCOHOL; BENZODIAZEPINE; CALCIUM CHANNEL; CALCIUM CHANNEL L TYPE; CYCLOOXYGENASE 2 INHIBITOR; DIZOCILPINE; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; OPIATE RECEPTOR; PROTEIN KINASE C; THEOPHYLLINE; CENTRAL DEPRESSANT AGENT;

ALCOHOL ABUSE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANTINOCICEPTION; DISEASE COURSE; DISEASE SEVERITY; DRUG DETOXIFICATION; DRUG TOLERANCE; HUMAN; HYPERALGESIA; IN VITRO STUDY; LATENT PERIOD; NERVE EXCITABILITY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RELAPSE; REVIEW; SEX DIFFERENCE; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; HOSPITALIZATION; MOUSE; PATHOPHYSIOLOGY; RAT; RECURRENT DISEASE; WITHDRAWAL SYNDROME;

ALCOHOL-INDUCED DISORDERS, NERVOUS SYSTEM; ANIMALS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DISEASE MODELS, ANIMAL; ETHANOL; HUMANS; HYPERALGESIA; MICE; RATS; RECURRENCE; SEVERITY OF ILLNESS INDEX; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 70349787217     PISSN: 18744737     EISSN: None     Source Type: Journal    
DOI: 10.2174/1874473710902010041     Document Type: Review

References (101)

1. Becker HC. Animal models of alcohol withdrawal. Alcohol Res Health 2000; 24: 105-13.
2. Gatch MB. Effects of benzodiazepines on acute and chronic ethanol-induced nociception in rats. Alcohol Clin Exp Res 1999; 23: 1736-43.
3. Gatch MB, Lal H. Effects of ethanol administration and withdrawal on thermal nociception in rats. Alcohol Clin Exp Res 1999; 23: 328-33.
4. Pohorecky L, Shah P. Ethanol-induced analgesia. Life Sci 1987; 41: 1289-95.
5. Holloway F, Miller J, King D, Bedingfield J. Delayed ethanol effects on physiological and behavioral indices in the rat. Alcohol 1993; 10: 511-9.
6. Jørgensen H, Hole K. Does ethanol stimulate brain opiate receptors? Studies on receptor binding and naloxone inhibition of ethanol-induced effects. Eur J Pharmacol 1981; 75: 223-9.
7. Campbell VC, Taylor RE, Tizabi Y. Antinociceptive effects of alcohol and nicotine: Involvement of the opioid system. Brain Res 2006; 1097: 71-7.
8. Friedman HJ, Bass MB, Lester D. Ethanol-induced analgesia in rats selectively bred for ethanol sensitivity. Pharmacol Biochem Behav 1980; 13: 773-6.
9. Franklin KB, Abbott V. Pentobarbital, diazepam, and ethanol abolish the interphase diminution of pain in the formalin test: evidence for pain modulation by GABAA receptors. Pharmacol Biochem Behav 1993; 46: 661-6.
10. Mogil JS, Marek P, Yirmiya R, et al. Antagonism of the non-opioid component of ethanol-induced analgesia by the NMDA receptor antagonist MK-801. Brain Res 1993; 602: 126-30.
11. Gatch MB. Tolerance to the antinociceptive effects of ethanol during ethanol withdrawal. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 946-52.
12. Khanna J, Mayer J, Le D, Kalant H. Differential response to ethanol, pentobarbital and morphine in mice selectively bred for ethanol sensitivity. Alcohol 1984; 1: 3-7.
13. Newman LM, Curran MA, Becker GL. Effects of chronic alcohol intake on anesthetic responses to diazepam and thiopental in rats. Anesthesiology 1986; 65: 196-200.
14. Lovinger DM, White G, Weight FF. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 1989; 243: 1721.
15. Hoffman P, Rabe C, Moses F, Tabakoff B. N-Methyl-D-aspartate receptors and ethanol: inhibition of calcium flux and cyclic GMP production. J Neurochem 1989; 52: 1937-40.
16. Coderre TJ, van Empel I. The utility of excitatory amino acid (EAA) antagonists as analgesic agents. II. Assessment of the antinociceptive activity of combinations of competitive and non-competitive NMDA antagonists with agents acting at allosteric-glycine and polyamine receptor sites. Pain 1994; 59: 353-9.
17. Coderre TJ, van Empel I. The utility of excitatory amino acid (EAA) antagonists as analgesic agents. I. Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical, thermal and chemical nociceptive tests. Pain 1994; 59: 345-52.
18. France CP, Snyder AM, Woods JH. Analgesic effects of phencyclidine-like drugs in rhesus monkeys. J Pharmacol Exp Ther 1989; 250: 197-201.
19. Uzbay IT, Wallis CJ, Lal H, Forster MJ. Effects of NMDA receptor blockers on cocaine-stimulated locomotor activity in mice. Behav Brain Res 2000; 108: 57-61.
20. Pohorecky L. The interaction of alcohol and stress. A review. Neurosci Biobehav Rev 1981; 5: 209-29.
21. Millan MJ. The induction of pain: An integrative review. Prog Neurobiol 1999; 57: 1-164.
22. Sawynok J, Liu XJ. Adenosine in the spinal cord and periphery: release and regulation of pain. Prog Neurobiol 2003; 69: 313-40.
23. Dunwiddie TV, Masino SA. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 2001; 24: 31-55.
24. Gatch MB, Selvig M. Theophylline blocks ethanol-withdrawal induced hyperalgesia. Alcohol Alcohol 2002; 37: 313-7.
25. Gameiro GH, Arthuri MT, Tambeli CH, de Arruda VMC. Effects of ethanol on deep pain evoked by formalin injected in TMJ of rat. Life Sci 2003; 73: 3351-61.
26. Gatch MB. Nitrendipine blocks the antinociceptive effects of chronically administered ethanol. Alcohol Clin Exp Res 2002; 26: 1181-7.
27. Malec D, Kotlinska J, Langwinski R. Cross-tolerance between morphine and ethanol and their antinociceptive effects. J Stud Alcohol 1987; 48: 507-10.
28. Dina OA, Barletta J, Chen X, et al. Key role for the epsilon isoform of protein kinase C in painful alcoholic neuropathy in the rat. J Neurosci 2000; 20: 8614-9.
29. Wong JO, Chang CL, Cheng JT. The effect of nifedipine on fentanyl-induced analgesia in rats. Acta Anaesthesiol Sin 1994; 32: 109-14.
30. Wong JO, Chin CW, Wu WH, Zbuzek VK. The effect of nifedipine and verapamil on nicotine-induced antinociception in rats. Life Sci 1994; 54: 1711-8.
31. Michaluk J, Karolewicz B, Antkiewicz-Michaluk L, Vetulani J. Effects of various Ca2+ channel antagonists on morphine analgesia, tolerance and dependence, and on blood pressure in the rat. Eur J Pharmacol 1998; 352: 189-97.
32. Hunt TE, Wu WH, Zbuzek VK. The effects of serotonin biosynthesis inhibition on nicotine and nifedipine-induced analgesia in rats. Anesth Analg 1998; 87: 1109-12.
33. Dolin SJ, Little HJ. Augmentation by calcium channel antagonists of general anaesthetic potency in mice. Br J Pharmacol 1986; 88: 909-14.
34. Damaj MI, Martin BR. Calcium agonists and antagonists of the dihydropyridine type: effect on nicotine-induced antinociception and hypomotility. Drug Alcohol Depend 1993; 32: 73-9.
35. Wong CH, Zbuzek VK, Wu WH. Tolerance-like phenomenon of nifedipine-induced antinociception. Life Sci 1996; 59: Pl277-281.
36. Wong CH, Wu WH, Zbuzek VK. Hypotension does not alter the antinociceptive effect of nifedipine. Life Sci 1998; 63: Pl343-8.
37. Potter JS, Prather K, Weiss RD. Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalities. Am J Addict 2008; 17: 121-5.
38. Dhir A, Naidu PS, Kulkarni SK. Protective effect of cyclooxygenase-2 (COX-2) inhibitors but not non-selective cyclooxygenase (COX)-inhibitors on ethanol withdrawal-induced behavioural changes. Addict Biol 2005; 10: 329-35.
39. Dina OA, Messing RO, Levine JD. Ethanol withdrawal induces hyperalgesia mediated by PKCepsilon. Eur J Neurosci 2006; 24: 197-204.
40. Shumilla JA, Liron T, Mochly-Rosen D, Kendig JJ, Sweitzer SM. Ethanol withdrawal-associated allodynia and hyperalgesia: age-dependent regulation by protein kinase C epsilon and gamma isoenzymes. J Pain 2005; 6: 535-49.
41. Shumilla JA, Sweitzer SM, Kendig JJ. Acute and chronic ethanol exacerbates formalin pain in neonatal rats. Neurosci Lett 2004; 367: 29-33.
42. Shumilla JA, Sweitzer SM, Kendig JJ. Acute and chronic ethanol does not affect incisional pain in neonatal rats. Neurosci Lett 2004; 366: 332-5.
43. Rogers DT, Barron S, Littleton JM. Neonatal ethanol exposure produces a hyperalgesia that extends into adolescence, and is associated with increased analgesic and rewarding properties of nicotine in rats. Psychopharmacology 2004; 171: 204-11.
44. Li HF, Mochly-Rosen D, Kendig JJ. Protein kinase Cgamma mediates ethanol withdrawal hyper-responsiveness of NMDA receptor currents in spinal cord motor neurons. Br J Pharmacol 2005; 144: 301-07.
45. Li HF, Kendig JJ. Ethanol withdrawal hyper-responsiveness mediated by NMDA receptors in spinal cord motor neurons. Br J Pharmacol 2003; 139: 73-80.
46. Bridges D, Thompson SW, Rice AS. Mechanisms of neuropathic pain. Br J Anaesth 2001; 87: 12-26.
47. Mao J, Mayer DJ. Spinal cord neuroplasticity following repeated opioid exposure and its relation to pathological pain. Ann N Y Acad Sci 2001; 933: 175-85.
48. Negus SS, Butelman ER, Ai Y, Woods JH. Prostaglandin E2-induced thermal hyperalgesia and its reversal by morphine in the warm-water tail-withdrawal procedure in rhesus monkeys. J Pharmacol Exp Ther 1993; 266: 1355-63.
49. Ibuki T, Marsala M, Masuyama T, Yaksh TL. Spinal amino acid release and repeated withdrawal in spinal morphine tolerant rats. Br J Pharmacol 2003; 138: 689-97.
50. Dunbar SA, Pulai IJ. Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat. J Pharmacol Exp Ther 1998; 284: 678-86.
51. Dunbar S, Yaksh TL. Concurrent spinal infusion of MK801 blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the rat. Anesthesiology 1996; 84: 1177-88.
52. De Beun R, Schneider R, Klein A, Lohmann A, De Vry J. Effects of nimodipine and other calcium channel antagonists in alcohol-preferring AA rats. Alcohol 1996; 13: 263-71.
53. Brennan CH, Crabbe J, Littleton JM. Genetic regulation of dihydropyridine-sensitive calcium channels in brain may determine susceptibility to physical dependence on alcohol. Neuropharmacology 1990; 29: 429-32.
54. Whittington MA, Dolin SJ, Patch TL, Siarey RJ, Butterworth AR, Little HJ. Chronic dihydropyridine treatment can reverse the behavioural consequences of and prevent adaptations to, chronic ethanol treatment. Br J Pharmacol 1991; 103: 1669-76.
55. Colombo G, Agabio R, Lobina C, et al. Effects of the calcium channel antagonist darodipine on ethanol withdrawal in rats. Alcohol Alcohol 1995; 30: 125-31.
56. Littleton JM, Little HJ, Whittington MA. Effects of dihydropyridine calcium channel antagonists in ethanol withdrawal; doses required, stereospecificity and actions of Bay K 8644. Psychopharmacology 1990; 100: 387-92.
57. Little HJ, Dolin SJ, Halsey MJ. Calcium channel antagonists decrease the ethanol withdrawal syndrome. Life Sci 1986; 39: 2059-65.
58. Whittington MA, Little HJ. A calcium channel antagonist stereoselectively decreases ethanol withdrawal hyperexcitability but not that due to bicuculline, in hippocampal slices. Br J Pharmacol 1991; 103: 1313-20.
59. Whittington MA, Little HJ. Nitrendipine, given during drinking, decreases the electrophysiological changes in the isolated hippocampal slice, seen during ethanol withdrawal. Br J Pharmacol 1991; 103: 1677-84.
60. Dolin SJ, Little HJ. Are changes in neuronal calcium channels involved in ethanol tolerance? J Pharmacol Exp Ther 1989; 250: 985-91.
61. Gatch MB, Wallis CJ, Lal H. The effects of adenosine ligands R-PIA and CPT on ethanol withdrawal. Alcohol 1999; 19: 9-14.
62. Concas A, Cuccheddu T, Floris S, Mascia MP, Biggio G. 2-Chloro-N6-cyclopentyladenosine (CCPA), an adenosine A1 receptor agonist, suppresses ethanol withdrawal syndrome in rats. Alcohol Alcohol 1994; 29: 261-4.
63. Concas A, Mascia MP, Cuccheddu T, et al. Chronic ethanol intoxication enhances [3H]CCPA binding and does not reduce A1 adenosine receptor function in rat cerebellum. Pharmacol Biochem Behav 1996; 53: 249-55.
64. Malec D, Michalska E, Pikulicka J. Influence of adenosinergic drugs on ethanol withdrawal syndrome in rats. Pol J Pharmacol 1996; 48: 583-8.
65. Coe IR, Dohrman DP, Constantinescu A, Diamond I, Gordon AS. Activation of cyclic AMP-dependent protein kinase reverses tolerance of a nucleoside transporter to ethanol. J Pharmacol Exp Ther 1996; 276: 365-9.
66. Sapru M, Diamond I, Gordon A. Adenosine receptors mediate cellular adaptation to ethanol in NG108-15 cells. J Pharmacol Exp Ther 1994; 271: 542-8.
67. Wannamaker VL, Nagy LE. Equilibrative adenosine transport in rat hepatocytes after chronic ethanol feeding. Alcohol Clin Exp Res 1995; 19: 735-40.
68. Szot P, Sanders RC, Murray TF. Theophylline-induced upregulation of A1-adenosine receptors associated with reduced sensitivity to convulsants. Neuropharmacology 1987; 26: 1173-80.
69. Dunbar SA, Karamov IG, Buerkle H. The effect of spinal ibuprofen on opioid withdrawal in the rat. Anesth Analg 2000; 91: 417-22.
70. Dunbar SA, Karamian I, Zhang J. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat. Eur J Pain 2006; in press.
71. Motta EM, Calixto JB, Rae GA. Mechanical hyperalgesia induced by endothelin-1 in rats Is mediated via phospholipase C, protein kinase C, and MAP kinases. Exp Biol Med 2006; 231: 1141-5.
72. Sweitzer SM, Wong SM, Tjolsen A, Allen CP, Mochly-Rosen D, Kendig JJ. Exaggerated nociceptive responses on morphine with-drawal: roles of protein kinase C epsilon and gamma. Pain 2004; 110: 281-9.
73. Mogil JS, Sternberg WF, Kest B, Marek P, Liebeskind JC. Sex differences in the antagonism of swim stress-induced analgesia: effects of gonadectomy and estrogen replacement. Pain 1993; 53: 17-25.
74. Kavaliers M, Galea L. Sex differences in the expression and antagonism of swim stress-induced analgesia in deer mice vary with the breeding season. Pain 1995; 63: 327-34.
75. Fink G, Sarkar DK, Dow RC, et al. Sex difference in response to alphaxalone anaesthesia may be oestrogen dependent. Nature 1982; 298: 270-2.
76. Jung ME, Wallis CJ, Gatch MB, Lal H. Sex differences in anxiogenic stimuli induced by m-chlorophenylpiperazine or ethanol withdrawal. Psychopharmacology 2000; 149: 170-5.
77. Lal H, Harris CM, Benjamin D, Springfield AC, Bhadra S, Emmett-Oglesby MW. Characterization of a pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal. J Pharmacol Exp Ther 1988; 247: 508-18.
78. Jung ME, Wallis CJ, Gatch MB, Lal H. Sex differences in the pentylenetetrazol-like stimulus induced by ethanol withdrawal. J Pharmacol Exp Ther 1999; 291: 576-82.
79. Jung ME, Wallis CJ, Gatch MB, Lal H. Sex differences in nicotine substitution to a pentylenetetrazol discriminative stimulus during ethanol withdrawal. Psychopharmacology 2000; 149: 235-40.
80. Gatch MB, Lal H. Animal models of the anxiogenic effects of ethanol withdrawal. Drug Dev Res 2001; 54: 95-115.
81. Devaud LL, Matthews DB, Morrow AL. Gender impacts behavioral and neurochemical adaptations in ethanol-dependent rats. Pharmacol Biochem Behav 1999; 64: 841-9.
82. Devaud LL, Purdy RH, Morrow AL. The neurosteroid, 3 alphahydroxy-5 alpha-pregnan-20-one, protects against bicuculline-induced seizures during ethanol withdrawal in rats. Alcohol Clin Exp Res 1995; 19: 350-5.
83. El-Mas MM, Abdel-Rahman AA. Ovariectomy alters the chronic hemodynamic and sympathetic effects of ethanol in radiotelemetered female rats. Clin Exp Hypertens 2000; 22: 109-26.
84. Grant KA, Werner R, Hoffman PL, Tabakoff B. Chronic tolerance to ethanol in the N:NIH rat. Alcohol Clin Exp Res 1989; 13: 402-06.
85. Compton P, Athanasos P, Elashoff D. Withdrawal hyperalgesia after acute opioid physical dependence in nonaddicted humans: a preliminary study. J Pain 2003; 4: 511-9.
86. Sweitzer SM, Allen CP, Zissen MH, Kendig JJ. Mechanical allodynia and thermal hyperalgesia upon acute opioid withdrawal in the neonatal rat. Pain 2004; 110: 269-80.
87. Juni A, Klein G, Kest B. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems. Brain Res 2006; 1070: 35-44.
88. Damaj MI, Kao W, Martin BR. Characterization of spontaneous and precipitated nicotine withdrawal in the mouse. J Pharmacol Exp Ther 2003; 307: 526-34.
89. Grabus SD, Martin BR, Batman AM, Tyndale RF, Sellers E, Damaj MI. Nicotine physical dependence and tolerance in the mouse following chronic oral administration. Psychopharmacology 2005; 178: 183-92.
90. Salas R, Pieri F, De Biasi M. Decreased signs of nicotine withdrawal in mice null for the beta4 nicotinic acetylcholine receptor subunit. J Neurosci 2004; 24: 10035-9.
91. Schmidt BL, Tambeli CH, Gear RW, Levine JD. Nicotine withdrawal hyperalgesia and opioid-mediated analgesia depend on nicotine receptors in nucleus accumbens. Neuroscience 2001; 106: 129-36.
92. Aley K, Green P, Levine J. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal. J Neurosci 1995; 15: 8031-8.
93. Wallen MC, Lorman WJ, Gosciniak JL. Combined buprenorphine and chlonidine for short-term opiate detoxification: patient perspectives. J Addict Dis 2006; 25: 23-31.
94. Miller NS, Swiney T, Barkin RL. Effects of opioid prescription medication dependence and detoxification on pain perceptions and self-reports. Am J Ther 2006; 13: 436-44.
95. Compton P, Charuvastra VC, Ling W. Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent. Drug Alcohol Depend 2001; 63: 139-46.
96. McLeary PE, Leander JD, Mello NK, et al. Clonidine analgesia and suppression of operant responding: dissociation of mechanism. Eur J Pharmacol 1981; 69: 63-9.
97. Fielding S, Spaulding TC, Lal H. Antinociceptive actions of clonidine. Prog Clin Biol Res 1981; 71: 225-42.
98. Eissenberg T. Measuring the emergence of tobacco dependence: the contribution of negative reinforcement models. Addiction 2004; 99: 5-29.
99. Koob GF, Nestler EJ. The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci 1997; 9: 482-97.
100. Koob GF, Roberts AJ, Schulteis G, et al. Neurocircuitry targets in ethanol reward and dependence. Alcohol Clin Exp Res 1998; 22: 3-9.
101. Chester JA, Rausch EJ, June HL, Froehlich JC. Decreased reward during acute alcohol withdrawal in rats selectively bred for low alcohol drinking. Alcohol 2006; 38: 165-72.